跳至主要内容
临床试验/EUCTR2017-001369-25-DE
EUCTR2017-001369-25-DE进行中(未招募)1 期

The Sensitivity and Specificity of the Modified Helicobacter Test INFAI Using New Test Meal with 13C-Urea Breath Test in Helicobacter Pylori Positive and Negative Patients with Dyspepsia and GERD Taking Proton Pump Inhibitors

INFAI Institut für biomedizinische Analytik und NMR Imaging GmbH0 个研究点目标入组 226 人开始时间: 2018年2月1日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
226

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Male and female patients of at least 18 years of age
  • All acid-related disorders requiring long-term PPI treatment including functional dyspepsia and GERD according Rome IV classification
  • Positive or negative standard 13C-UBT at screening.
  • Diagnosis of H. pylori infection confirmed or excluded by combination of culture#, histology* and rapid** urease test (PyloriTek®, Serim Research Corp., Elkhart, USA) on samples obtained by endoscopy:
  • -True positive: culture and/or (histology and rapid urease test) are positive
  • -True negative: at least two tests are negative and culture is not positive
  • -True negative: culture not evaluable and both histology and urease test are negative.
  • -Patients will undergo upper endoscopy. Six biopsy samples will be obtained during this procedure.
  • #)Culture will be based on antrum and corpus 2 biopsies.
  • *)two biopsies ( corpus and antrum ) for histology
  • **) two biopsies ( corpus and antrum ) for Rapid urease test(RUT)
  • Written informed consent of the patient.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 156
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 70

排除标准

  • Previous H. pylori eradication therapy.
  • Intake of PPI in 2 weeks, H2 receptor antagonists 1 day and NSAIDs, antibiotics, anti¬secretory drugs, bismuth compounds, or sucralfate in the 4 weeks prior to enrolment.
  • Manifest coagulopathy or any other disorder according to which endoscopy and/or biopsies are contraindicated.
  • Participation in a clinical trial with another not approved drug within 30 days before entering the study and/or previous participation in this study.

研究者

发起方
INFAI Institut für biomedizinische Analytik und NMR Imaging GmbH

相似试验

A clinical study to investigate a new test meal for... | 临床试验